VWO vs XBI
Vanguard FTSE Emerging Markets ETF vs SPDR S&P Biotech ETF
- • VWO has the lower expense ratio at 0.06% vs 0.35% for XBI.
- • VWO pays a higher dividend yield (2.19%).
Side-by-side metrics
| Metric | VWO | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.06% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.19% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $153.78B | $10.92B |
YTD return | 5.62% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.78 | 1.01 |
P/E ratio | 15.59 | — |
Last price | $57.34 | $156.41 |
Inception | — | — |
Issuer | Vanguard | State Street |
VWO top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 15.75% |
| 0700.HK | Tencent Holdings Ltd | 2.82% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 2.11% |
| 2454.TW | MediaTek Inc | 1.88% |
| 2308.TW | Delta Electronics Inc | 0.95% |
| 00939 | China Construction Bank Corp Class H | 0.91% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.79% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.70% |
| RELIANCE.NS | Reliance Industries Ltd | 0.69% |
| 01398 | Industrial And Commercial Bank Of China Ltd Class H | 0.65% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About VWO
VWO (Vanguard FTSE Emerging Markets ETF) is Stocks in emerging-market economies. Managed by Vanguard, the fund carries $153.8B in assets under management, an expense ratio of 0.06%, a dividend yield of 2.19%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 15.7% of the portfolio. Real Estate is the fund's largest sector exposure at 2.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.